A detailed history of Loomis Sayles & CO L P transactions in Alkermes Plc. stock. As of the latest transaction made, Loomis Sayles & CO L P holds 1,882,936 shares of ALKS stock, worth $55.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,882,936
Previous 404,514 365.48%
Holding current value
$55.8 Million
Previous $9.75 Million 440.61%
% of portfolio
0.07%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.01 - $28.55 $34 Million - $42.2 Million
1,478,422 Added 365.48%
1,882,936 $52.7 Million
Q2 2024

Aug 13, 2024

SELL
$23.21 - $27.24 $8.42 Million - $9.88 Million
-362,563 Reduced 47.27%
404,514 $9.75 Million
Q1 2024

May 14, 2024

SELL
$26.4 - $32.56 $135,168 - $166,707
-5,120 Reduced 0.66%
767,077 $20.8 Million
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $2.02 Million - $2.47 Million
86,270 Added 12.58%
772,197 $21.4 Million
Q3 2023

Nov 09, 2023

BUY
$27.17 - $31.97 $8.64 Million - $10.2 Million
317,920 Added 86.39%
685,927 $19.2 Million
Q2 2023

Aug 11, 2023

BUY
$28.34 - $33.63 $1.05 Million - $1.24 Million
37,013 Added 11.18%
368,007 $11.5 Million
Q1 2023

May 11, 2023

BUY
$25.31 - $29.02 $8.38 Million - $9.61 Million
330,994 New
330,994 $9.33 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.